Polymorphism in the promoter of the CCL5 gene (CCL5 G-403A) in a cohort of North Indian children with Kawasaki disease. A preliminary study

Clinical and Experimental Rheumatology

Volumn 29, Issue 1 SUPPL. 64, 2011, Pages

  Chaudhuri, K ^a   Singh Ahluwalia, T ^a   Singh, Surjit ^a   Binepal, G ^a   Khullar, M ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chandigarh; Genetics; Kawasaki disease; North India

Indexed keywords

RANTES; CHEMOKINE RECEPTOR CCR5;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL PERFUSION IMAGING; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; CCL5 GENE; CORONARY ARTERY DILATATION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOKINE CCL5; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; LOGISTIC MODELS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, CCR5; RISK ASSESSMENT; RISK FACTORS; SEQUENCE DELETION;

EID: 79960392842     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. PETTY RE, CASSIDY JT: Kawasaki disease. In: CASSIDY JT, PETTY RE (Eds.): Textbook of Pediatric Rheumatology, 5th ed. Philadelphia: WB Saunders Company 2005, p. 580- 94.
2. BROGAN PA, BOSE A, BURGNER D et al.: Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002; 86: 286-90.
3. NEWBURGER JW, TAKAHASHI M, GERBER MA et al.: Diagnosis, Treatment, and long-term management of Kawasaki Disease: a statement for health professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease,Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004; 114: 1708-33.
4. KAWASAKI T: General review and problems in Kawasaki Disease. Jpn Heart J 1995; 36: 1-12.
5. SINGH S: Kawasaki disease: a clinical dilemma. Indian Pediatr 1999; 36: 871-75.
6. HIRATA S, NAKAMURA Y, YANAGAWA H: Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr 2001; 90: 40-44.
7. ROWLEY AH, WOLINSKY SM, RELMAN DA et al.: Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res 1994; 36: 567-71.
8. BURNS JC, SHIMIZU C, SHIKE H et al.: Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun 2005; 6: 438-44.
9. BURNS JC, SHIMIZU C, GONZALER E et al.: Genetic variations in Receptor-Ligand pair CCR5, and CCL3LI are important determinants of susceptibility to Kawasaki disease. J Infect Dis 2005; 192: 344-9.
10. UEHARA R, YASHIRO M, NAKAMURA Y, YANAGAWA H: Kawasaki disease in parents and children. Acta Paediatr 2003; 92: 694-97.
11. BALARAJAN R: Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ 1991; 302: 560-4.
12. OZEN S, RUPERTO N, DILLON MJ et al.: EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 7: 936-41.
13. YANG J, LI CR, LI YB et al.: The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter. Zhonghua Er Ke Za Zhi 2003; 4: 598-602.
14. FURUNO K, TAKADA H, YAMAMOTO K et al.: Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease. J Pediatr 2007; 151: 155-60.
15. CHIEN YH, CHANG KW, YANG YH, LU MY, LIN YT, CHIANG BL: Association between levels of TNF-alpha and TNF-alpha promoter -308 A/A polymorphism in children with Kawasaki disease. J Formos Med Assoc 2003; 102: 147-50.
16. BURGNER D, DAVILA S, BREUNIS WB et al.; INTERNATIONAL KAWASAKI DISEASE GENETICS CONSORTIUM: A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 2009; 5: e1000319.
17. KOTHUR K, SINGH S, SHARMA Y, MITTAL BR: Prospective follow-up cardiac evaluation of children with Kawasaki disease in Northern India using the Japanese echocardiography criteria. J Cardiol 2007; 50: 299-307.
18. LAHIRI DK, NURNBERGER JI JR: A rapid non enzymatic method for the preparation of high molecular weight DNA from blood for RFLP studies. Nuc Acid Res 1991; 19: 5444.
19. MAKKI RF, AL SHARIF F, GONZALEZ- GAY MA, GARCIA-PORRUA COLLIER WE, HAJEER AH: RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Clin Exp Rheumatol 2000; 18: 391-93.
20. AHLUWALIA TS, AHUJA M, RAI TS, KOHLI HS, BHANSALI A, SUD K, KHULLAR M: ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol 2009; 28: 141-50.
21. KUSHNER HI, MACNEE R, BURNS JC et al.: Impressions of Kawasaki syndrome in India. Indian Pediatr 2006; 43: 939-42.
22. YANAGAWA H, YASHIRO M, NAKAMURA Y, KAWASAKI T, KATO H: Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics 1995; 95: 475-9.
23. SINGH S, BANSAL A, GUPTA A, KUMAR RM, MITTAL BR: Kawasaki disease: a decade of experience from North India. Int Heart J 2005; 46: 679-89.
24. MELISH ME, HICKS RM, LARSON EJ: Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 1976; 130: 599-607.
25. SINGH S, GUPTA MK, BANSAL A, GUPTA A, KUMAR RM, MITTAL BR: A comparison of the clinical profile of Kawasaki disease in children from North India above and below 5 years of age. Clin Exp Rheumatol 2007; 25: 654-57.
26. SIMEONI E, WINKELMANN BR, HOFFMANN MN et al.: Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 2004; 25: 1438-46.
27. BREUNIS WB, BIEZEVELD MH, GEISSLER J et al.: Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Expl Immunol 2007; 150: 83-90.
28. KAUR G, SINGH P, RAPTHAP CC et al.: Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians. Hum Immunol 2007 68: 454-61.
29. GALVANI AP, NOVEMBRE J: The evolutionary history of the CCR5- Delta32 HIV-resistance mutation. Microbes Infect 2005; 7: 302-9.
30. FUKUDA T, ISHIBASHI M, YOKOYAMA T et al.: Myocardial ischemia in Kawasaki disease: evaluation with dipyridamole stress technetium 99m tetrofosmin scintigraphy. J Nucl Cardiol 2002; 9: 632-7.
31. ZANON G, ZUCCHETTA P, VARNIER M, VITTADELLO F, MILANESI O, ZULIAN F: Do Kawasaki disease patients without coronary artery abnormalities need a long-term follow-up? A myocardial single-photon emission computed tomography pilot study. J Paediatr Child Health 2009; 45: 419-24.
32. KATO S, OHTA T, SUZUKI Y, MATSUYAMA S: Thallium-201 myocardial imaging in Kawasaki disease. Tokai J Exp Clin Med 1982; 7: 69-75.
33. HOSHINA M, SHIRAISHI H, IGARASHI H, KIKUCHI Y, ICHIHASHI K, MOMOI MY: Efficacy of iodine-123-15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid single photon emission computed tomography imaging in detecting myocardial ischemia in children with Kawasaki disease. Circ J 2003; 67: 663-6.